Ken Fisher Purple Biotech Ltd. Transaction History
Fisher Asset Management, LLC
- $229 Billion
- Q2 2024
Shares
1 transactions
Others Institutions Holding PPBT
# of Institutions
23Shares Held
1.91MCall Options Held
5.6KPut Options Held
0-
Armistice Capital, LLC New York, NY1.36MShares$7.33 Million0.01% of portfolio
-
Kingswood Wealth Advisors, LLC San Diego, CA208KShares$1.12 Million0.01% of portfolio
-
Morgan Stanley New York, NY203KShares$1.1 Million0.0% of portfolio
-
Ken Griffin Citadel Advisors LLC | Chicago, Il24.6KShares$132,9910.0% of portfolio
-
Venture Visionary Partners LLC22.2KShares$119,6690.0% of portfolio
About PURPLE BIOTECH LTD.
- Ticker PPBT
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 18,303,300
- Market Cap $98.8M
- Description
- Purple Biotech Ltd., a clinical-stage company, focuses on developing therapies to overcome tumor immune evasion and drug for cancer patients in the United States. Its oncology pipeline includes CM24, a monoclonal antibody that blocks carcinoembryonic antigen related cell adhesion molecule 1 as a combination therapy with anti-PD-1 checkpoint inhi...